Dephosphorylation of RalA leads to the subsequent inactivation of RalA, and of PP2A-Aβ losing its regulatory tumour suppressive capabilities, resulting in failure to reverse tumourigenic phenotypes and cellular dysfunction [51, 56]. This evidence concerns the gene RALA and neoplasm.